CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.
| Website: | www.cytosorbents.com |
| Email: | avogel@cytosorbents.com |
| Main Phone: | +1 732 329-8885 |
| Address: | 7 Deer Park Drive |
| Address 2: | Suite K |
| State: | NJ |
| City / Town: | Monmouth Junction |
| Country: | USA |
| Postal Code: | 08852 |
| Exchange: | NSC |
| CEO: | Phillip P. Chan |
| Employees: | 101 |
| NAICS: | Medical Laboratories(621511) |
| Last Price 12.95 | Change $ -0.1 | Change % -0.77 | Tick N/A |
| Bid 12.75 | Bid Size 500.00 | Ask 13.45 | Ask Size 400.00 |
| Open 13.10 | High 13.40 | Low 12.88 | Prev Close 13.05 |
| Last Trade | Volume 181,226 | 52 Wk Hi 14.95 | 52 Wk Low 5.35 |
| Market Cap 407.4 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 31,459,443.00 | EPS (TTM) -0.47 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 26 | 55 |
| Number of Buys | 13 | 33 |
| Number of Sells | 13 | 22 |
| Net Activity | 24785 | 225628 |
| Last 10 Buys | Shares |
|---|---|
| Michael G. Bator | 1,000 |
| Eric R. Mortensen | 1,000 |
| Phillip P. Chan | 1,000 |
| Edward R. Jones | 1,000 |
| Edward R. Jones | 1,000 |
| Vincent Capponi | 1,000 |
| Phillip P. Chan | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Phillip P. Chan | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Vincent Capponi | 1,000 |
| Vincent Capponi | 1,000 |
| Vincent Capponi | 1,000 |
| Vincent Capponi | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Vincent Capponi | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Vincent Capponi | 1,000 |
| Vincent Capponi | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 14 | 14 | 14 | 14 |
| Low Target Price Estimate | 11 | 11 | 11 | 11 |
| Mean Target Price Estimate | 12.6 | 12.6 | 12.6 | 12.6 |
| Standard Deviation | 1.14 | 1.14 | 1.14 | 1.14 |
| Date of Most Recent Estimate | 05/23/18 | 05/23/18 | 05/23/18 | 05/23/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-18 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-06-14 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-05-24 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 73 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
